.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports..
corinna's twin boys -- maarten, left, and linus -- were the first humans to be treated for their genetic disorder while still inside the womb.